- The US Food and Drug Administration has accused Pfizer of laxity in reporting serious side effects from some of its major products, including its best-selling calcium antagonist for hypertension, Procardia XL (nifedipine), and the antidepressant Zoloft (sertraline). Last year and in 1994, Pfizer reported side effects with its products between 77 and 514 days late, according to the agency, which adds that other violations dating back to 1983 have been uncovered.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze